This is the largest orphan drug industry event.

CONFERENCE

Speak at World Orphan Drug Congress USA

With keynotes, interactive discussions, workshops and roundtables, this event is designed to tackle the most important challenges facing the orphan drug and rare disease  industry.

READ MORE

EXHIBIT

Exhibit at World Orphan Drug Congress USA

This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

READ MORE

NETWORK

Network at World Orphan Drug Congress USA

We offer a variety of networking opportunities from Speed Networking to 1-2-1 Partnering sessions ro ensure that you meet as many other attendees as possible in 2 days.

READ MORE

Photos from WODC USA 2015

"WORLD ORPHAN DRUG CONGRESS IS THE PLACE TO BE FOR THE LEADERS IN THE RARE DISEASE COMMUNITY"


Hans Schikan, Chief Executive Officer, Prosensa Therapeutics Bv

World Orphan Drug Congress USA 

Speakers at this year’s meeting included C-level executives and decision makers from the leading orphan drug manufacturers, policy makers and influencers, patient advocacy group leaders from different regions of the world.

Showcase your expertise alongside inspirational speakers

Henri Termeer at World Orphan Drug Congress USA

Henri Termeer

Chief Investment Officer, Former

Genzyme

Christoffer Nellaker at World Orphan Drug Congress USA

Christoffer nellaker

Research Fellow, Medical Research Foundation's Functional Genomics Unit

Oxford University

 

Jeff Myers at World Orphan Drug Congress USA

Jeff myers

President and Chief Executive Officer

Medicaid Health Plans of America 
(MHPA)

Julie Stoss at World Orphan Drug Congress USA

Julie Stoss

Vice President, Government Relations

Kaiser Permanente  

Eric Hoffman at World Orphan Drug Congress USA

Eric Hoffman

Director, Research Center for Genetic Medicine

Children's National Hospital​  

Who attends?

Here's a glimpse of who attended in 2015

AccessPharmaCon,LLC Aegerion Pharmaceuticals  Aetna Pharmacy Management  Alexion Pharmaceuticals  Andarix Pharmaceuticals  ArmaGen Technologies, Inc.  Ashfield Healthcare   Asklepion Pharmaceuticals LLC  Ax-S Pharma  B.D.C. Venture Capital  BioBlast Pharma Ltd  Biomarin Pharmaceutical Inc.  BioPontis Alliance for Rare Disease Brace Pharma Capital   Brazilian Federal Council of Medicine  Bristol-Myers Squibb  CatalentPharma Solutions   CatalystPharmaceutical Partners  CDER FDA  Clear Pharma  Clementia Pharmaceuticals Inc.   Clinuvel Pharmaceuticals Ltd  Dicerna Pharmaceuticals  DrugDev  EvaluatePharma Ltd   Genoa Pharmaceuticals   Genpharm  GenSight Biologics  Genzyme Corp  Giddi Pharma Co., Ltd.   Idera Pharmeceuticals  IDIS Pharma   Iptechex Pharmalicensing  Jazz Pharmaceuticals, Inc  Juice Pharma Worldwide   KBI Biopharma Inc   Lumos Pharma   M3 Pharma  Marathon Pharmaceuticals LLC   Marinus Pharmaceuticals  Momenta Pharmaceuticals Inc  Opsona Therapeutics Ltd  Optio Biopharma Solutions LLC  Orpharma  Pfizer, Inc  Pharmaceutics International In  Pharmaessentia Corp   Pharnext   Portola Pharmaceuticals , Inc.  Provectus PharmaceuticalsInc   QuayPharma  Quintiles Inc  Raptor Pharmaceuticals Corp  Reata Pharmaceuticals   Recordati S.p.A  Recursion Pharmaceuticals  Retrophin   Sanofi   Savara Pharmaceuticals  Seattle Children's Research Institute   Shire Pharmaceuticals Inc  Taiba Pharma LLC Teva  Threshold Pharmaceuticals Inc   Tolero Pharmaceuticals   Ultragenyx Pharmaceutical Inc.  Valley Fever Solutions   Vanda Pharmaceuticals Inc   Vertex Pharmaceuticals 

Photos from WODC USA 2015

"THE UN OF ORPHAN DRUGS"


2015 Conference delegate

Are you looking to meet CEOs, VPs and Directors working in R&D, Business Development, Regulatory Access, Market Access, Commercial, Marketing and Brand/Product from pharma and biotech?

Then you need to join our sponsors at World Orphan Drug Congress USA 2016.

  • Gold Sponsor

    MAPI at World Orphan Drug Congress USA 2016

    Platinum Sponsor

    Premier Research at World Orphan Drug Congress USA 2016
  • Silver Sponsor

    Lapidus Data at World Orphan Drug Congress USA 2016

    Silver Sponsor

    Quintiles at World Orphan Drug Congress USA 2016
  • Bronze Sponsor

    Clear Pharma at World Orphan Drug Congress USA 2016

    Bronze Sponsor

    Patient Crossroads at World Orphan Drug Congress USA 2016
  • Bronze Sponsor

    Medical Marketing Economics at World Orphan Drug Congress USA 2016

    Bronze Sponsor

    One-World, inc at World Orphan Drug Congress USA 2016
  • Bronze Sponsor

    PRA International at World Orphan Drug Congress USA 2016

    Exhibitor

    Omnicare Specialty Care Group at World Orphan Drug Congress USA 2016
  • Exhibitor

    Clinart MENA at World Orphan Drug Congress USA 2016

    Exhibitor

    Cote Orphan at World Orphan Drug Congress USA 2016
  • Exhibitor

    Dohmen Life Science Services at World Orphan Drug Congress USA 2016

    Exhibitor

    Pharmaceutics International Inc at World Orphan Drug Congress USA 2016
  • Exhibitor

    PSR-Agility at World Orphan Drug Congress USA 2016
 

Register Now

THIS CONFERENCE WILL SELL OUT!
Early registration and partner discounts available.
Click below for the full list of ticket options...

 
US Market Size Infographic

Infographic: What is the size of the Orphan Drugs Market in the USA?

Here at World Orphan Drug Congress USA, we understand that sometimes it is really useful to have the stats! So here they are – in ...

The post Infographic: What is the size of the Orphan Drugs Market in the USA? appeared first on Orphan Drugs.

“Path to Commercialization: Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases

Teresa Leezer of RhinoCyte, Inc.   joined us for World Orphan Drug Congress USA 2015 to present about ‘ Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases’  Download ...

The post “Path to Commercialization: Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases appeared first on Orphan Drugs.

“SCENESSE®: Commercialization of a First-In-Class NCE”

Nicoletta Muner of Clinuvel Pharmaceuticals Ltd.   joined us for World Orphan Drug Congress USA 2015 to present about ‘ SCENESSE®    :Commercialization of a First-In-Class NCE’  Download her presentation ...

The post “SCENESSE®: Commercialization of a First-In-Class NCE” appeared first on Orphan Drugs.

Join the Community

Strategy and innovation for the orphan drug and rare disease industry

Sign Up to Our Newsletter